KYVERNA THERAPEUTICS, INC.

Highlights Kyverna Therapeutics, Inc.

Equities

KYTX

US5019761049

Market Closed - Nasdaq Other stock markets 21:00:00 21/06/2024 BST			5-day change	1st Jan Change
7.73 ^USD	-3.74%		-18.89%	0.00%

06-20	Sector Update: Health Care Stocks Higher Late Afternoon	MT
06-20	Kyverna Therapeutics Gets FDA Investigational New Drug Application Clearance for KYV-101 to Treat Stiff-Person Syndrome	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sector Update: Health Care Stocks Higher Late Afternoon	06-20	MT
Kyverna Therapeutics, Inc.'s KYV-101 Receives U.S. FDA IND Clearance for Treatment of Patients with Treatment-Refractory Stiff-Person Syndrome in the KYSA-8 Phase 2 Trial	06-20	CI
Kyverna Therapeutics, Inc. Announces First-In-Disease Use of it's KYV-101 in Patient with Severe Stiff-Person Syndrome Published in Results	06-17	CI
Sector Update: Health Care Stocks Decrease Late Afternoon	06-14	MT
Sector Update: Health Care	06-14	MT
Kyverna Therapeutics Shares Fall After Early Data on CAR T Cell Therapy Candidate	06-14	MT
Kyverna Therapeutics Q1 Loss Narrows	05-14	MT
Kyverna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Nasdaq's revenue beats on strong demand for fintech products	04-25	RE
Kyverna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Kyverna Therapeutics Teams Up With Stanford University to Evaluate Investigational Multiple Sclerosis Drug	03-08	MT
Kyverna Therapeutics and Stanford University Agree to Evaluate KYV-101 in Patients with Non-Relapsing and Progressive Forms of Multiple Sclerosis	03-08	CI
Kyverna Therapeutics Closes $366.9 Million Initial Public Offering	02-13	MT
Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut	02-09	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer